Potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment

Crisaborole 2% ointment is a non-steroidal treatment for mild-moderate atopic dermatitis (AD) and may produce fewer adverse effects than topical corticosteroids (TCS). We used PS-OCT to quantify dermal collagen at baseline and after 29 days of treatment with crisaborole and betamethasone valerate (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, M. Q., Byers, Robert A., Danby, Simon G., Sahib, Sura, Cha, Amy, Zang, Chuanbo, Werth, John, Adiri, Roni, Taylor, Rosie N., Cork, Michael J., Matcher, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Optica Publishing Group 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549734/
https://www.ncbi.nlm.nih.gov/pubmed/37799702
http://dx.doi.org/10.1364/BOE.494464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549734/
https://www.ncbi.nlm.nih.gov/pubmed/37799702
http://dx.doi.org/10.1364/BOE.494464

Ejemplares similares